Lori Lyons-Williams
Directeur/Membre du Conseil chez CONTINEUM THERAPEUTICS, INC.
Fortune : - $ au 30/04/2024
Profil
Ms. Lori M.
Lyons-Williams is a President & Chief Executive Officer at Abdera Therapeutics, Inc. and an Independent Director at Rapt Therapeutics, Inc. She is on the Board of Directors at Rapt Therapeutics, Inc., Contineum Therapeutics, Inc. and National Association for Continence.
Ms. Lyons-Williams was previously employed as an Independent Director by Five Prime Therapeutics, Inc., a Chief Commercial Officer by Dermira, Inc., a Vice President-Sales & Marketing by Allergan, Inc., and a Chief Operating Officer by Neumora Therapeutics, Inc. She also served on the board at Girls, Inc. She received her undergraduate degree from Virginia Polytechnic Institute & State University and an MBA from The Curtis L.
Carlson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RAPT THERAPEUTICS, INC.
-.--% | 28/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
| 05/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Lori Lyons-Williams
| Sociétés | Poste | Début |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/08/2020 |
| RAPT THERAPEUTICS, INC. | Directeur/Membre du Conseil | 09/11/2021 |
National Association for Continence
 National Association for Continence Miscellaneous Commercial ServicesCommercial Services National Association for Continence is a non profit organization provides healthcare services. It offers public education and advocacy about the causes, prevention, diagnosis, treatments, and management alternatives for incontinence. The company was founded by Katherine F. Jeter in September 1982 and is headquartered in Philadelphia, PA | Directeur/Membre du Conseil | - |
Abdera Therapeutics, Inc.
 Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Directeur Général | 01/05/2022 |
Anciens postes connus de Lori Lyons-Williams
| Sociétés | Poste | Fin |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | President | 01/01/2020 |
| FIVE PRIME THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/04/2021 |
| DERMIRA, INC. | Corporate Officer/Principal | 01/01/2020 |
| ALLERGAN, INC. | Sales & Marketing | 01/08/2016 |
Girls, Inc.
 Girls, Inc. Miscellaneous Commercial ServicesCommercial Services Girls, Inc. provides educational programs for girls. It offers healthy living, academic enrichment and support and life skill instruction. The company was founded in 1864 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Formation de Lori Lyons-Williams
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
| The Curtis L. Carlson School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| RAPT THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
National Association for Continence
National Association for Continence Miscellaneous Commercial ServicesCommercial Services National Association for Continence is a non profit organization provides healthcare services. It offers public education and advocacy about the causes, prevention, diagnosis, treatments, and management alternatives for incontinence. The company was founded by Katherine F. Jeter in September 1982 and is headquartered in Philadelphia, PA | Commercial Services |
Girls, Inc.
Girls, Inc. Miscellaneous Commercial ServicesCommercial Services Girls, Inc. provides educational programs for girls. It offers healthy living, academic enrichment and support and life skill instruction. The company was founded in 1864 and is headquartered in New York, NY. | Commercial Services |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Health Technology |
